Anpac Bio-Medical Science Co. sell Lokrim
Start price
19.08.23
/
20%
€1.97
Target price
19.08.24
-
Performance (%)
-77.46%
End price
19.01.24
€0.44
Summary
This prediction ended on 19.01.24 with a price of €0.44. Lokrim correctly predicted massive losses of -77.46% for Anpac Bio-Medical Science Co.. Lokrim has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Anpac Bio-Medical Science Co. | - | - | - |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% |
According to Lokrim what are the pros and cons of Anpac Bio-Medical Science Co. for the foreseeable future?
Pros
Cons
Risky Investment
Comments by Lokrim for this prediction
In the thread AnPac Bio-Medical Science Co. Ltd. ADR diskutieren
Sell Anpac Bio-Medical Science Co.